Navarro A P, Sohrabi S, Wilson C, Sanni A, Wyrley-Birch H, Vijayanand D, Reddy M, Rix D, Manas D, Talbot D
Liver and Renal Transplant Unit, Freeman Hospital, Newcastle upon Tyne, United Kingdom.
Transplant Proc. 2006 Oct;38(8):2635-6. doi: 10.1016/j.transproceed.2006.08.007.
Kidneys transplanted from non-heart-beating donors (NHBDs) have been exposed to varying degrees of ischemic damage after death. Category III donors have invariably been managed, treated, and investigated in a hospital setting prior to arrest and death. Some therefore exhibit evidence of renal dysfunction and even acute renal failure (ARF) before death. Many surgeons would regard a NHBD with pre-arrest evidence of ARF as too marginal for renal transplantation. This retrospective study examines five Maastricht category III NHBD donors with evidence of pre-arrest ARF. We compare 3- and 12-month GFR outcome data from the nine resulting transplants with 40 category III NHBD transplants with normal pre-arrest renal function. The mean GFR at 3 months was 45.4 and 43.8 for the ARF and normal group, respectively. At 12 months the GFR was 42.2 and 44.7 in the ARF and normal groups, respectively. Thus evidence of ARF pre-arrest does not preclude successful category III NHBD renal transplantation.
来自非心脏跳动供体(NHBDs)的肾脏在供体死亡后会遭受不同程度的缺血损伤。Ⅲ类供体在心跳停止和死亡前一直在医院环境中接受管理、治疗和检查。因此,一些供体在死亡前表现出肾功能不全甚至急性肾衰竭(ARF)的迹象。许多外科医生会认为,在心跳停止前有ARF迹象的NHBD进行肾移植的风险太大。这项回顾性研究调查了5例在心跳停止前有ARF迹象的马斯特里赫特Ⅲ类NHBD供体。我们将由此产生的9例移植手术在3个月和12个月时的肾小球滤过率(GFR)结果数据,与40例心跳停止前肾功能正常的Ⅲ类NHBD移植手术的数据进行了比较。ARF组和正常组在3个月时的平均GFR分别为45.4和43.8。在12个月时,ARF组和正常组的GFR分别为42.2和44.7。因此,心跳停止前有ARF迹象并不排除Ⅲ类NHBD肾移植成功。